enVVeno Medical CorpNVNO

時価総額
$323万
PER
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
Cash and cash equivalents3195554
Short-term investments----3443
Prepaid expenses and other current assets64,306116,647234,467312,35001
Total Current Assets3110553947
Total Current Assets3110553947
Property and equipment, net26,153344,027398,967617,85510
Operating lease right-of-use assets, net-826,397539,974221
Security deposits and other assets---54,49300
Total Assets4311584249
Accounts payable111560,0831-
Accounts payable, accrued expenses and other current liabilities-----1
Accrued expenses and other current liabilities----1-
Current portion of operating lease liabilities-288,685314,202291,10400
Current portion of operating lease liabilities-288,685314,202291,10400
Total Current Liabilities-23221
Total Current Liabilities-23221
Long-term operating lease liabilities-567,948253,746211
Long-term operating lease liabilities-567,948253,746211
Total Liabilities223332
Total Liabilities223332
Common stock, par value $0.00001, 250,000 shares authorized, 13,317 and 9,472 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively1171792595--
Common stock, par value $0.00001, 250,000 shares authorized, 13,317 and 9,472 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively1171792595--
Additional paid-in capital515772136145176
Additional paid-in capital515772136145176
Accumulated deficit-48,562,528-56,187,925-65,323,411-81,851,233-107-130
Accumulated deficit-48,562,528-56,187,925-65,323,411-81,851,233-107-130
Total Stockholders’ Equity2989,9407543946
Total Stockholders’ Equity2989,9407543946
Common stock, par value $0.00001, 250,000 shares authorized, 13,317 and 9,472 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively1171792595--
Common stock, par value $0.00001, 250,000 shares authorized, 13,317 and 9,472 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively1171792595--
Additional paid-in capital515772136145176
Additional paid-in capital515772136145176
Accumulated deficit-48,562,528-56,187,925-65,323,411-81,851,233-107-130
Accumulated deficit-48,562,528-56,187,925-65,323,411-81,851,233-107-130
Total Stockholders’ Equity2989,9407543946
Total Stockholders’ Equity2989,9407543946
Total Liabilities and Stockholders’ Equity4311584249
Total Liabilities and Stockholders’ Equity4311584249